Navigation Links
Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
Date:7/17/2008

SOUTH SAN FRANCISCO, Calif., July 17 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that it has begun a Phase 2 clinical trial of Adlea(TM), the company's long-acting, site specific, non-opioid drug candidate for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair.

Adlea is currently in two pivotal Phase 3 trials in the U.S.: one in total knee replacement surgeries and one in bunionectomy surgeries. An additional Phase 2 Adlea trial is in progress in total hip replacement surgeries. These trials are among those intended to support an Adlea label indication for the management of acute pain following orthopedic surgery.

The Phase 2 arthroscopic shoulder surgery trial is being conducted in South Korea. Unlike the United States, where the procedure is often conducted on an outpatient basis, arthroscopic shoulder surgery patients in South Korea are routinely hospitalized for up to two days, thus allowing more extensive near-term follow-up.

"We believe Adlea holds promise for treating pain associated with a number of orthopedic surgical indications, and may reduce the need for other pain treatments such as opioids," said Michael L. Kranda, Anesiva's president and chief executive officer. "As we pursue a broad indication of management of post-surgical pain following orthopedic procedures, each specific procedure that we can evaluate will add to the breadth of available data for Adlea."

Arthroscopic surgery is performed through small incisions using an arthroscope, or camera, to visualize the inside of a joint. Through the incisions, a surgeon inserts a camera and small instruments to perform the procedure. According to the American Aca
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
2. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
3. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
4. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
5. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
6. Anesiva Defines Regulatory Pathway for Adlea with FDA
7. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
8. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
9. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
10. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
11. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009)...June 30 Cephalon, Inc. (...tted a supplemental New Drug Application (sNDA) to...sting approval of NUVIGIL(R) (armodafinil) Tablets... in patients with excessive sleepiness associated ...vel. Jet lag disorder is an acute condition that ...
(Date:6/29/2009)...nn., June 29 Pioneerin...ess of deep brain stimulation (DBS) in hard-to...OCD) and Tourette,s syndrome are underway at multi... a review in the June 2009 issue of Mayo Clin...g been seen as valuable for controlling movement d...
(Date:6/28/2009)...if., June 29 Sangamo Bio...hat a key research milestone has been achieved in ... Inc., a wholly-owned member of the Roche Group, f...eristics for pharmaceutical protein production pur...binding protein nuclease (ZFN) technology. Genente...
(Date:6/26/2009)...N.J., June 26 Sanofi-a...een made aware of data associated with a retrospec...ults of these data clearly show that no definitive...sal relationship between Lantus(R) (insulin glargi...ignancies, as the authors of the study point out. ...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 396 Well Filtration Plate From Varian Inc Improves Sensitivity and Precision for Trace Bio Analysis by LC MS 2918 196 Well Filtration Plate From Varian Inc Improves Sensitivity and Precision for Trace Bio Analysis by LC MS 2918 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 1Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 Express2 28TM 29 Stents or Bypass Surgery 7401 1Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 Express2 28TM 29 Stents or Bypass Surgery 7401 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 Express2 28TM 29 Stents or Bypass Surgery 7401 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 Express2 28TM 29 Stents or Bypass Surgery 7401 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 Express2 28TM 29 Stents or Bypass Surgery 7401 5Chrigu Wins Grand Prize at First Ever International Documentary Film Festival on Cancer 25917 1Chrigu Wins Grand Prize at First Ever International Documentary Film Festival on Cancer 25917 2Chrigu Wins Grand Prize at First Ever International Documentary Film Festival on Cancer 25917 3Chrigu Wins Grand Prize at First Ever International Documentary Film Festival on Cancer 25917 4
...point achieved -- , LAINATE, Italy - July 4, 2007 ...oday positive preliminary results from its,phase I...n,infectious diarrhoea. CB-01-11 is a broad spectr... when taken in tablet form. Through,the use of Cos...,ingredient into the colon, bacteria in the gastro...
....--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek tod...rmaceutical and,biotechnology companies to be firs...atment for cardiovascular disease. While,angiogene... Boston,Scientific, Baxter, and Genzyme, among oth...iological therapy for advanced,coronary artery dis...
Other Medicine Technology:Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2
(Date:7/2/2009)...tain mutations in the DNA of the hepatitis B virus...r cancer and may help predict which patients with ...e, according to a large meta-analysis in the Jour...nline July 2. , HBV infection is a known cause o...form of liver cancer. Previous studies have looked...
(Date:7/2/2009)...ESTON, Fla., July 2 Amer...), today announced that the Company,s Acting CFO, ...full-time to the position and has resigned from he.... , , Ms. McWilliams has held various position...r. She possesses in-depth, practical knowledge in...
(Date:7/2/2009)...EW YORK, July 2 "If rec...ael Jackson,s doctors will face intense scrutiny f...re. The pharmacists who filled Mr. Jackson,s presc... everyone whose name is associated with any of Jac...llin. , , Mr. Mullin won full federal jury ac...
(Date:7/2/2009)...mic virus affects lungs and stomach, whereas seaso...HURSDAY, July 2 (HealthDay News) -- Scientists hav...w swine flu frequently brings on gastrointestinal ...ated with seasonal flu. , In experiments with f...e Netherlands found that the new H1N1 flu virus re...
Breaking Medicine News(10 mins):Health News:American Scientific Resources Announces Acting CFO Transition to Full-Time 2Health News:DEA Will Play Hardball in Investigating Michael Jackson's Doctors 2Health News:Why Swine Flu Differs From Seasonal Flu 2Health News:Why Swine Flu Differs From Seasonal Flu 3
... fever for the loss of millions of hours of work p...00 people with hay fever symptoms, including sneez...that workers missed an hour of work per week durin...hile missing an hour of work a week may seem small...
...h real condoms, beer mugs in the condom shape, sta...eque that opens here// Wednesday will be like none...ndom bar", it aims to make people, especially youn...the need for safe sex. And that is not all. The b...
...s could be helpful to improve sexual dysfunction i...l dysfunction (FSD) includes a variety of disorder...ng sexual activity, problems with orgasm or pain d... can wreak havoc in even the most loving relations...
...eveler than any other disease. It strikes without ... color or sex//. When Shankar Vishwanath, 48, a te...lore visited a diagnostic facility for his annual ...d not but suspect him from inheriting the metaboli...
Other Medicine News:Health News:Hay Fever Can Send Work Productivity Down the Drain 2Health News:Hay Fever Can Send Work Productivity Down the Drain 3Health News:‘Condom Bar’ to Create Awareness Among Youngste 2Health News:Simple Changes in Diet Could Improve Sex Life of Women 2Health News:Diabetes The Leveler-Sweeping Across Nations 2
The new Bicycle Ergometer utilizes an electromagnetic braking system which guarantees years of reliable service while providing whisper-quiet operation. The hyperbolic workload control provides consi
... is advanced in patient safety, dependability and ...mill surface provides an extra margin of safety fo... slowly from a standstill to accommodate severely ...et operation facilitates accurate blood pressure m...
Quinton stress test systems feature our internationally-acclaimed algorithm that is used by thousands worldwide. This algorithm has a proven record for reliability and accuracy in demanding clinical
The CASE 8000 is one of the first, true point-of-care clinical information systems for the exercise environment. By combining the accuracy of our premiere exercise ECG system with the information acc
Medicine Products: